These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 5286310)

  • 21. Low dose cytosine arabinoside in adult acute non-lymphoid leukemia.
    Rossi Ferrini P; Ciolli S; Leoni F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():36-7. PubMed ID: 2713558
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
    Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
    Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experiences with daunomycin and cytosine arabinoside in the therapy of acute myeloid leukemias].
    Kreiter H; Begemann H; Rastetter J
    Med Klin; 1968 Dec; 63(51):2058-66. PubMed ID: 5255517
    [No Abstract]   [Full Text] [Related]  

  • 24. High-dose cytosine arabinoside in the treatment of childhood malignancies.
    Lie SO; Slørdahl S
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):160-5. PubMed ID: 3859931
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytosine arabinoside in the treatment of advanced lymphoblastic leukemia in children].
    Halikowski B; Armata J; Cyklis R; Garwicz S; Wyszkowski J
    Pol Tyg Lek; 1969 Jul; 24(30):1152-4. PubMed ID: 5257715
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
    Hirano M; Uetani T; Morita A; Sako F; Koie K
    Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current methods in the treatment of acute leukemias in pediatric age].
    Zuelzer WW; Ravindranath Y; Mastrangelo R
    Recenti Prog Med; 1975 Oct; 59(4):353-71. PubMed ID: 769105
    [No Abstract]   [Full Text] [Related]  

  • 28. [Low-dose cytosine arabinoside in the therapy of varicella in childhood leukaemia (author's transl)].
    Carnelli V; Uderzo C; Gargantini G; Porcelli P; Giulotto P; Masera G
    Haematologica; 1978 Oct; 63(5):561-8. PubMed ID: 107075
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cytosine-arabinoside in the treatment of acute myeloblastic leukemias].
    Maroncelli P; Canova R; Casalino C; Fischioni P
    Minerva Med; 1971 Mar; 62(21):1110-9. PubMed ID: 5279670
    [No Abstract]   [Full Text] [Related]  

  • 31. [Problems in treating acute leukemias].
    Mendeleev IM
    Probl Gematol Pereliv Krovi; 1979 Sep; 24(9):16-23. PubMed ID: 386301
    [No Abstract]   [Full Text] [Related]  

  • 32. High-dose cytosine arabinoside in the initial treatment of acute leukemia.
    Barnett MJ; Waxman JH; Richards MA; Ganesan TS; Bragman KS; Rohatiner AZ; Lister TA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):133-8. PubMed ID: 3859927
    [No Abstract]   [Full Text] [Related]  

  • 33. Respiratory insufficiency in acute leukemia following treatment with cytosine arabinoside and septicemia with streptococcus viridans.
    Dybedal I; Lamvik J
    Eur J Haematol; 1989 Apr; 42(4):405-6. PubMed ID: 2721663
    [No Abstract]   [Full Text] [Related]  

  • 34. High-dose cytosine arabinoside: advances in clinical pharmacology and therapeutic results.
    Woodruff RK; Wiley JS
    Aust N Z J Med; 1983 Dec; 13(6):561-3. PubMed ID: 6586146
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytosine arabinoside and 6-thioguanine in refractory acute lymphocytic leukemia.
    Bryan JH; Henderson ES; Leventhal BG
    Cancer; 1974 Feb; 33(2):539-44. PubMed ID: 4521473
    [No Abstract]   [Full Text] [Related]  

  • 36. Experience with intermediate- and high-dose cytosine arabinoside in relapsed and refractory acute leukaemia.
    Willemze R; Fibbe WE; Zwaan FE
    Neth J Med; 1983; 26(8):215-9. PubMed ID: 6580554
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recent concepts of the therapy of acute "lymphoblastic" leukemia in infancy].
    Schwarz-Tiene E; Masera G
    Pediatria (Napoli); 1971; 79(1):13-26. PubMed ID: 5286090
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 39. Experiences with cytosine arabinoside in childhood leukaemia and lymphoma.
    Lay HN; Colebatch JH; Ekert H
    Med J Aust; 1971 Jul; 2(4):187-92. PubMed ID: 5285817
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results in the treatment of acute granulocytic leukemias using a combination of daunorubicine-cytosine arabinoside-cyclophosphamide. Apropos of 35 cases].
    Bauters F; Plouvier B; Caulier MT; Mouton J; Goudemand M
    Lille Med; 1974 Mar; 19(3):226-31. PubMed ID: 4612276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.